210 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
and deployment of capacity toward future commercial manufacturing under our existing Bioservices contracts; our ability to collect reimbursement for raw materials
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
toward future commercial manufacturing under our existing Bioservices contracts; our ability to collect reimbursement for raw materials and payment
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
purchases under the contract, or (c) reimbursement. Historical Lots- Testing Program and Quarantine Doses manufactured and distributed prior to 2018
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
ability to collect reimbursement for raw materials and payment of services fees from our Bioservices customers; the results of pending stockholder
8-K
EX-99.2
kv08xnue626kdo0mb4iv
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
ktyy69d
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
yntexd897etsf6v4fr9d
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.2
yhsw6tgl
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
zv4fh2eekq r3
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
5gey7ce
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
h68tps6ct kzbf
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.2
uiy9qrnd1oy936nl
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.1
6chpasu1 r6e
31 May 23
Departure of Directors or Certain Officers
5:00pm